Encapsulated cell grafts to treat cellular deficiencies and dysfunction.
about
Biomaterials as carrier, barrier and reactor for cell-based regenerative medicineIn vitro and in vivo evaluation of SU-8 biocompatibilityNoninvasive evaluation of the vascular response to transplantation of alginate encapsulated islets using the dorsal skin-fold modelBiocompatible coating of encapsulated cells using ionotropic gelation.Islet and stem cell encapsulation for clinical transplantationDAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1.A tunable silk-alginate hydrogel scaffold for stem cell culture and transplantation.Characterization of a bioactive fiber scaffold with entrapped HUVECs in coaxial electrospun core-shell fiber.Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro.What would surgeons like from materials scientists?Current status of islet encapsulation.Immunological and technical considerations in application of alginate-based microencapsulation systems.Effect of alginate microencapsulation on the catalytic efficiency and in vitro enzyme-prodrug therapeutic efficacy of cytosine deaminase and of recombinant E. coli expressing cytosine deaminase.Concise Review: Innate and Adaptive Immune Recognition of Allogeneic and Xenogeneic Cell Transplants in the Central Nervous System.Enhancement of in vitro and in vivo function of agarose-encapsulated porcine islets by changes in the islet microenvironment.Noninvasive Tracking of Alginate-Microencapsulated Cells.Preparation and microscopy examination of alginate-poly-L-lysine-alginate microcapsules.
P2860
Q28083709-A7562288-F98F-433B-8D7B-02A6C2B32C21Q29391458-59D76950-07E7-4CEB-AB56-638ABC3A70D3Q30580697-AC40D261-2BF8-4B5B-A7C0-6AEB03BB2C30Q31139164-C2767923-B65A-4C47-A1DE-1DBC7167657FQ34972386-BA89C69F-83B3-45FB-A544-64298F78F66BQ36106557-DCBEA5BC-A73C-40CF-AB72-A46B9EF037EFQ37677874-8C3B3B7F-BAF0-45F4-A7F4-8EDA732D5029Q37687001-5B577852-5DD6-4A7F-8205-362C08FC9F5BQ37710737-E87C8EBF-1F0D-46A7-94A1-E2FE41B70B72Q38093549-C76539AB-589A-4A2D-8EF4-0BF65597C2FFQ38123626-8E794A51-57B0-4058-9B83-97412A8657FCQ38242227-C1142A7C-3EDB-48E5-803A-01004FA036E8Q38813959-5229A66A-5FB9-45B3-97DD-07F256A6BA29Q39154189-25484C2F-9FC6-46DD-87CD-A0D3564A7E47Q45941829-017B2EAC-A252-4A44-90B8-20F50E01ACD9Q48593704-B88C625C-2500-4ADA-977D-29477EB02CFAQ53614227-4B3B1CAA-E2F0-4849-A014-7519015E3005
P2860
Encapsulated cell grafts to treat cellular deficiencies and dysfunction.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Encapsulated cell grafts to treat cellular deficiencies and dysfunction.
@en
Encapsulated cell grafts to treat cellular deficiencies and dysfunction.
@nl
type
label
Encapsulated cell grafts to treat cellular deficiencies and dysfunction.
@en
Encapsulated cell grafts to treat cellular deficiencies and dysfunction.
@nl
prefLabel
Encapsulated cell grafts to treat cellular deficiencies and dysfunction.
@en
Encapsulated cell grafts to treat cellular deficiencies and dysfunction.
@nl
P2860
P1476
Encapsulated cell grafts to treat cellular deficiencies and dysfunction.
@en
P2093
Barjor Gimi
N V Krishnamurthy
P2860
P304
P356
10.1615/CRITREVBIOMEDENG.V39.I6.10
P577
2011-01-01T00:00:00Z